A clinical phase II study of a non-anthracycline sequential combination of cisplatin-vinorelbine followed by docetaxel as first-line treatment in metastatic breast cancer.

Ali Shamseddine,Zaher K. Otrock,Mohamad Khalifeh,H. Yassine,Maya Charafeddine,Zeina Abdel-Khalek,Aref Chehal,Nizar Bitar,Rahif Jalloul,Moussa Dheiny,Azzam Dandashi,Mahmoud Wehbeh,Nagi S. El-Saghir

A clinical phase II study of a non-anthracycline sequential combination of cisplatin-vinorelbine followed by docetaxel as first-line treatment in metastatic breast cancer.

2006

Ali Shamseddine
Zaher K. Otrock
Mohamad Khalifeh
H. Yassine
Maya Charafeddine
Zeina Abdel-Khalek
Aref Chehal
Nizar Bitar
Rahif Jalloul
Moussa Dheiny
Azzam Dandashi
Mahmoud Wehbeh
Nagi S. El-Saghir

Background: We tested a sequential combination regimen using cisplatin and vinorelbine (PVn) followed by docetaxel as first-line chemotherapy in a phase II clinical trial in metasta

Keywords:

Pathology
Regimen
Phases of clinical research
Vinorelbine
Cisplatin
Anthracycline
Medicine
Metastatic breast cancer
Chemotherapy
Docetaxel

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations